Recreational drugs and fetal gastroschisis: Maternal hair analysis in the peri-conceptional period and during pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 8, 2005, Pages 1022-1025

  Morrison, John J ^a,b   Chitty, Lynn S ^a   Peebles, Donald ^a   Rodeck, Charles H ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

RECREATIONAL DRUG; STREET DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONCEPTION; CONTROLLED STUDY; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL GASTROSCHISIS; FETUS; GAS CHROMATOGRAPHY; GASTROSCHISIS; HAIR ANALYSIS; HUMAN; MASS SPECTROMETRY; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ENVIRONMENTAL EXPOSURE; GESTATIONAL AGE; HAIR; MASS FRAGMENTOGRAPHY; MATERNAL CARE; METHODOLOGY; PRENATAL DIAGNOSIS; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTROSCHISIS; GESTATIONAL AGE; HAIR; HUMANS; MATERNAL EXPOSURE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY TRIMESTERS; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 24344457330     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00655.x     Document Type: Article

References (34)

1. Wilson RD, Johnson MP. Congenital abdominal wall defects; an update. Fetal Diagn Ther 2004;19(5):385-398.
2. Nichols CR, Dickinson JE, Pemberton PJ. Rising incidence of gastroschisis in teenage pregnancies. J Matern Fetal Med 1997;6:225-229.
3. Boyd PA, Bhattacharjee A, Gould S, Manning N, Chamberlain P. Outcome of prenatally diagnosed anterior abdominal wall defects. Arch Dis Child Fetal Neonatal Ed 1998;78:F209-F213.
4. Davies BW, Stringer MD. The survivors of gastroschisis. Arch Dis Child 1997;77:158-160.
5. Morrison JJ, Klein N, Chitty LS, et al. Intra-amniotic inflammation in human gastroschisis: possible aetiology of postnatal bowel dysfunction. Br J Obstet Gynaecol 1998;105:1200-1204.
6. Tan KH, Kilby MD, Whittle MJ, Beattie BR, Booth IW, Bolting BJ. Congenital anterior abdominal wall defects in England and Wales 1987-1993: retrospective analysis of OPCS data. BMJ 1996;313:903-906.
7. Martinez-Frias MLSO. Gastroschisis: is the prevalence increasing? Am J Med Genet 1994;49:397-403.
8. Penman DG, Fisher RM, Noblett HR, Soothill PW. Increase in incidence of gastroschisis in the South West of England in 1995. Br J Obstet Gynaecol 1998;105:328-331.
9. Werler MM, Mitchell AA, Shapiro SS. Demographic, reproductive, medical and environmental factors in relation to gastroschisis. Teratology 1992;45:353-360.
10. Hoyme HE, Higginbottom MC, Jones KL. The vascular pathogenesis of gastroschisis: intrauterine interruption of the omphalomesenteric artery. J Pediatr 1981;98:228-231.
11. Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ. A population-based study of gastroschisis: demographic, pregnancy and lifestyle risk factors. Teratology 1994;50:44-53.
12. Hume Jr RF, Gingras JL, Martin LS, Hertzberg BS, O'Donnell K, Killam AP. Ultrasound diagnosis of fetal anomalies associated with in utero cocaine exposure: further support for cocaine-induced vascular disruption teratogenesis. Fetal Diagn Ther 1994;9:239-245.
13. Hume Jr RF, Martin LS, Bottoms SF, et al. Vascular disruption birth defects and history of prenatal cocaine exposure: a case control study. Fetal Diagn Ther 1997;12:292-295.
14. Nakahara Y, Shimamine M, Takahashi K. Hair analysis for drugs of abuse. III. Movement and stability of metoxyphenamine (as a model compound of methamphetamine) along hair shaft with hair growth. J Anal Toxicol 1992;16:253-257.
15. Miyazawa N, Uematsu T. Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis. Ther Drug Monit 1992;14:525-528.
16. Gardner MJ, Gardner SB, Winter PD. Confidence interval analysis: microcomputer program. BMJ 1989.
17. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse-the Canadian experience. Forensic Sci Int 2000;107:281-288.
18. Spiehler V. Hair analysis by immunological methods from the beginning to 2000. Forensic Sci Int 2000;107:249-259.
19. McNagny SE, Parker RM. High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. JAMA 1992;267:1106-1108.
20. Kline J, Ng SK, Schittini M, Levin B, Susser M. Cocaine use during pregnancy: sensitive detection by hair assay. Am J Public Health 1997;87:352-358.
21. Martinez F, Poet TS, Pillai R, Erickson J, Estrada AL, Watson RR. Cocaine metabolite (benzoylecgonine) in hair and urine of drug users. J Anal Toxicol 1993;17:138-142.
22. Grant T, Brown Z, Callahan C, Barr H, Streissguth AP. Cocaine exposure during pregnancy: improving assessment with radioimmunoassay of maternal hair. Obstet Gynaecol 1994;83:524-531.
23. Keller T, Miki A, Regenscheit P, Dirnhofer R, Schneider A, Tsuchihashi H. Detection of designer drugs in human hair by ion mobility spectrometry (IMS). Forensic Sci Int 1998;94:55-63.
24. Callahan CM, Grant TM, Phipps P, et al. Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium and urine. J Pediatr 1992;120:763-768.
25. Ness RB, Grisso JA, Hirschinger MA, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999;340:333-339.
26. Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998;25:119-138.
27. Colado ML, O'Shea E, Granados R, Misra A, Murray TK, Green AR. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol 1997;121:827-833.
28. Dickinson JE, Andres RL, Parisi VM. The ovine fetal sympatho-adrenal response to the maternal administration of methamphetamine. Am J Obstet Gynecol 1994;170:452-457.
29. Stek AM, Baker RS, Fisher BK, Lang U, Clark KE. Fetal responses to maternal and fetal methamphetamine administration in sheep. Am J Obstet Gynecol 1995;173:1592-1598.
30. Nora JJ, Vargo TA, Nora AH, Love KE, McNamara DG. Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet 1970;1:1290-1291.
31. Bays J. Fetal vascular disruption with prenatal exposure to cocaine or methamphetamine. Pediatrics 1991;87:416-418.
32. Little BB, Snell LM, Gilstrap LC. methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988;75:541-544.
33. van Tonningen-van Driel MM, Garbis-Berkvens JM, Reuvers-Lodewijks WE. Pregnancy outcome after ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment. Ned Tijdschr Geneeskd 1999;143:27-31.
34. Webster WS, Brown-Woodman PD. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology 1990;41:689-697.